INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
SEC FORM 4/Option exerciseVerified data

Stone Warren reported NEO

Pres & Chief Operating Officer · NEOGENOMICS INC · Common Stock

Side
M
Value
—
Shares
59.4K
Price
—
Executed
Jan 13, 2026
Disclosed
Jan 15, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Jan 13 executedJan 15, 2026 disclosed

NEO · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
21/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Option exercise — administrative, little informational value

  • Relative size+13 / 25

No reported dollar value · 59.7% of prior position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · NEO

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    28
    Gilbert Ray Cisneros, Jr.DSelf
    NEONEOGENOMICS INC
    Purchase
    		BUY$1,001 – $15KAug 7, 2026Sep 10, 2026
    traded Aug 7, 2026
    		+34dHOUSE PTR

    Evidence

    17
    OC
    Olivo Alicia CEVP, GC & Business Development
    NEONEOGENOMICS INC
    Option exercise
    		M—
    59.4K sh
    		Jan 13, 2026Jan 15, 2026
    traded Jan 13, 2026
    		+2dSEC FORM 4

    Evidence

    13
    OC
    Olivo Alicia CEVP, GC & Business Development
    NEONEOGENOMICS INC
    Tax withholding
    		F—
    15.1K sh
    		Jan 13, 2026Jan 15, 2026
    traded Jan 13, 2026
    		+2dSEC FORM 4

    Evidence

    13
    SW
    Stone WarrenPres & Chief Operating Officer
    NEONEOGENOMICS INC
    Tax withholding
    		F—
    15.1K sh
    		Jan 13, 2026Jan 15, 2026
    traded Jan 13, 2026
    		+2dSEC FORM 4

    Evidence

    16
    OC
    Olivo Alicia CEVP, GC & Business Development
    NEONEOGENOMICS INC
    Option exercise · 10b5-1 plan
    		M$90K
    8,977 sh
    		Nov 25, 2025Nov 28, 2025
    traded Nov 25, 2025
    		+3dSEC FORM 4

    Evidence

    25
    OC
    Olivo Alicia CEVP, GC & Business Development
    NEONEOGENOMICS INC
    Open-market sale · 10b5-1 plan
    		SELL$251K
    20.9K sh
    		Nov 25, 2025Nov 28, 2025
    traded Nov 25, 2025
    		+3dSEC FORM 4

    Evidence

    13
    OC
    Olivo Alicia CEVP, GC & Business Development
    NEONEOGENOMICS INC
    Option exercise · 10b5-1 plan
    		M—
    8,977 sh
    		Nov 25, 2025Nov 28, 2025
    traded Nov 25, 2025
    		+3dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001628280-26-002199
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Jan 13, 2026
    Published
    Jan 15, 2026
    Ingested by INSIDER
    Nov 5, 04:22 UTC
    Last re-read
    Nov 5, 04:22 UTC

    Extracted facts

    Filer
    Stone Warren
    Role
    Pres & Chief Operating Officer
    Transaction
    Option exerciseAs filed: “M”
    Asset
    NEOGENOMICS INC
    Ticker
    NEO
    Shares
    59.4K
    Price per share
    $0
    Execution date (reported)
    Jan 13, 2026
    Owned after transaction
    158.9K shares
    Days from execution to publication
    2

    What this establishes

    Stone Warren filed this Form 4 reporting a option exercise of NEO on Jan 13, 2026. It became public on Jan 15, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Pres & Chief Operating Officer
    Stone Warrencik:0001955295
    Issuer
    NEOGENOMICS INCcik:0001077183

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.